Haemonetics Corp. diskutieren
Haemonetics Corp.
WKN: 881782 / Symbol: HAE / Name: Haemonetics / Aktie / Ausrüstung & Versorgung / Mid Cap /
72,00 €
-1,33 %
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Needham & Company LLC from $108.00 to $104.00. They now have a "buy" rating on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Needham & Company LLC from $104.00 to $84.00. They now have a "buy" rating on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its "strong-buy" rating re-affirmed by analysts at Raymond James. They now have a $105.00 price target on the stock, down previously from $115.00.
Ratings data for HAE provided by MarketBeat
Haemonetics Corporation (NYSE: HAE) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $87.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Corporation (NYSE: HAE) was upgraded by analysts at Baird R W to a "strong-buy" rating.
Ratings data for HAE provided by MarketBeat
Haemonetics Corporation (NYSE: HAE) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $90.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Corporation (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $95.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Corporation (NYSE: HAE) had its price target lowered by analysts at Needham & Company LLC from $84.00 to $68.00. They now have a "buy" rating on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics (NYSE:HAE) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $86.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics (NYSE:HAE) had its price target lowered by analysts at Citigroup Inc. from $78.00 to $64.00. They now have a "buy" rating on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics (NYSE:HAE) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $86.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics (NYSE:HAE) had its price target raised by analysts at BTIG Research from $85.00 to $88.00. They now have a "buy" rating on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics (NYSE:HAE) had its price target raised by analysts at Barrington Research from $86.00 to $90.00. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in Northrop Grumman Corp. diskutieren